Guidelines for the Reporting of Treatment Trials for Alcohol Use Disorders.

Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. Alcohol Clin Exp Res (2015) 0.80

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers. Addiction (2016) 0.76

Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development. Alcohol Clin Exp Res (2016) 0.75

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41

The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70

Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48

Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol (1997) 11.33

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

The ClinicalTrials.gov results database--update and key issues. N Engl J Med (2011) 9.83

Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA (2014) 6.76

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85

The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend (1996) 5.35

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98

A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend (2000) 4.92

Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry (2005) 4.84

Medicine. Moving toward transparency of clinical trials. Science (2008) 4.36

CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev (2012) 3.37

Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev (2011) 3.23

The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol (2006) 3.02

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.00

Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials. Alcohol Clin Exp Res (2010) 2.89

Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv (2003) 2.77

Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med (2014) 2.67

Missing data in alcohol clinical trials: a comparison of methods. Alcohol Clin Exp Res (2013) 2.65

Alcohol treatment research assessment exposure subject reactivity effects: part I. Alcohol use and related consequences. J Stud Alcohol Drugs (2007) 2.19

A vision of the next generation of behavioral therapies research in the addictions. Addiction (2007) 2.09

Regression to the mean in substance use disorder treatment research. Addiction (2007) 2.06

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ (2001) 1.95

Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94

Measures of fidelity in motivational enhancement: a systematic review. J Subst Abuse Treat (2006) 1.87

Comparison of individual and group cognitive-behavioral therapy for alcohol and/or drug-dependent patients. Addiction (2001) 1.84

Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry (2000) 1.81

Training, supervision and quality monitoring of the COMBINE Study behavioral interventions. J Stud Alcohol Suppl (2005) 1.70

Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res (2010) 1.60

The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med (2014) 1.51

Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36

The randomized controlled trial: gold standard, or merely standard? Perspect Biol Med (2005) 1.35

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clin Trials (2006) 1.34

Is low therapist empathy toxic? Psychol Addict Behav (2012) 1.28

What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res (2007) 1.26

Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs (2011) 1.25

Distinctions without a difference: direct comparisons of psychotherapies for alcohol use disorders. Psychol Addict Behav (2008) 1.25

Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success. Alcohol Clin Exp Res (2003) 1.23

A controlled field trial of group versus individual cognitive-behavioural training for relapse prevention. Addiction (1996) 1.20

The forest and the trees: relational and specific factors in addiction treatment. Addiction (2014) 1.18

Ensuring the comparability of comparison groups: is randomization enough? Control Clin Trials (2004) 1.16

Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev (2013) 1.15

Eliminating bias in randomized controlled trials: importance of allocation concealment and masking. Fam Med (2007) 1.15

Pharmacotherapy of alcohol use disorders: seventy-five years of progress. J Stud Alcohol Drugs Suppl (2014) 1.14

Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction (2005) 1.14

Use of trial register information during the peer review process. PLoS One (2013) 1.13

Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial. Br J Psychiatry (2013) 1.12

Alcohol treatment research assessment exposure subject reactivity effects: part II. Treatment engagement and involvement. J Stud Alcohol Drugs (2007) 1.12

Concurrent validity of an online version of the Timeline Followback assessment. Psychol Addict Behav (2012) 1.12

On effect size. Psychol Methods (2012) 1.10

Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat (2009) 1.07

Randomized controlled trial of a cognitive-behavioral motivational intervention in a group versus individual format for substance use disorders. Psychol Addict Behav (2009) 1.06

Common statistical and research design problems in manuscripts submitted to high-impact psychiatry journals: what editors and reviewers want authors to know. J Psychiatr Res (2009) 1.06

A comparison of regression approaches for analyzing clustered data. Am J Public Health (2008) 1.05

A review of methods for ensuring the comparability of comparison groups in randomized clinical trials. Rev Recent Clin Trials (2006) 1.04

Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol Drugs (2008) 1.03

Modeling site effects in the design and analysis of multi-site trials. Am J Drug Alcohol Abuse (2011) 0.99

Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. Alcohol Clin Exp Res (2014) 0.98

Substance user treatment dropout from client and clinician perspectives: a pilot study. Subst Use Misuse (2009) 0.97

Can assessment reactivity predict treatment outcome among adolescents with alcohol and other substance use disorders? Subst Abus (2008) 0.95

Recruiting and retaining participants in a combined behavioral and pharmacological clinical trial. J Stud Alcohol Suppl (2005) 0.94

Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals. PLoS One (2013) 0.93

Improving the quality of reporting alcohol outcome studies: effects of the CONSORT statement. Addict Behav (2010) 0.93

The efficacy-effectiveness distinction in trials of alcohol brief intervention. Addict Sci Clin Pract (2014) 0.92

Sample Size Considerations in Prevention Research Applications of Multilevel Modeling and Structural Equation Modeling. Prev Sci (2015) 0.92

Alcohol assessment among college students using wireless mobile technology. J Stud Alcohol Drugs (2009) 0.91

Alcoholism treatment outcome studies, 1970-1998. An expanded look at the nature of the research. Addict Behav (2003) 0.90

Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study. J Clin Epidemiol (2011) 0.90

Intention-to-treat analyses and missing data approaches in pharmacotherapy trials for alcohol use disorders. BMJ Open (2013) 0.88

A qualitative analysis of women's experiences in single-gender versus mixed-gender substance abuse group therapy. Subst Use Misuse (2013) 0.84

An R package that automatically collects and archives details for reproducible computing. BMC Bioinformatics (2014) 0.84

Developing a baseline assessment battery: balancing patient time burden with essential clinical and research monitoring. J Stud Alcohol Suppl (2005) 0.84

Pretreatment changes in drinking: relationship to treatment outcomes. Psychol Addict Behav (2012) 0.83

Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment. Alcohol (2011) 0.82

Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. Alcohol Clin Exp Res (2015) 0.80

Coordinating and monitoring multisite clinical trials that combine pharmacological and behavioral treatments. J Stud Alcohol Suppl (2005) 0.80

Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2014) 0.80

Client-reported reasons for non-engagement in drug and alcohol treatment. Drug Alcohol Rev (2009) 0.78

Effective Strategies for Maintaining Research Participation in Clinical Trials. Drug Inf J (2009) 0.77

What happens when people discontinue taking medications? Lessons from COMBINE. Addiction (2014) 0.76

Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders. Alcohol Clin Exp Res (2015) 0.80